Top Markets
#1 Siren Siren +43.80%
#2 Seeker Seeker +24.90%
#3 Full Moon Full Moon +19.61%
#4 Wrapped NXM Wrapped NXM +12.15%
#5 Zora Zora +10.73%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +10.64%
#7 VVS Finance VVS Finance +9.99%
#8 Cryptopia Cryptopia +9.26%
#9 Axelar Axelar +8.27%
#10 Helium Helium +8.16%
Coin of the day
Siren Siren
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Intercept Pharmaceuticals, Inc. Intercept Pharmaceuticals, Inc.

Intercept Pharmaceuticals, Inc.

ICPT
Classificação em ações #12018
Intercept Pharmaceuticals, Inc. is a biopharmaceutical firm specializing in the... Intercept Pharmaceuticals, Inc. is a biopharmaceutical firm specializing in the advancement and market launch of therapies designed to treat progressive, non-viral liver conditions. Its operational reach spans the United States, Europe, and Canada. The company currently markets Ocaliva, a medication functioning as a farnesoid X receptor (FXR) agonist. This drug is approved for the treatment of primary biliary cholangitis (PBC) in adults, specifically when administered alongside ursodeoxycholic acid. Beyond its existing approved indications, Intercept is actively investigating Ocaliva's potential for additional uses, notably including nonalcoholic steatohepatitis (NASH). Concurrently, it is progressing other drug candidates through various clinical and preclinical stages of development. In a collaborative effort, the company holds a licensing agreement with Aralez Pharmaceuticals Canada Inc. to develop and commercialize bezafibrate in the United States. Intercept distributes its products through a dual approach, utilizing both its proprietary commercial organization and a network of external third-party distributors. The company was founded in 2002 and is headquartered in New York, New York.
Preço da ação
$19.00
Última sincronização: 2023-11-14
Valor de mercado
$629.64M
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar Intercept Pharmaceuticals, Inc. (ICPT)

Categoria

Healthcare
Histórico de preços das ações de Intercept Pharmaceuticals, Inc. (ICPT)
Preço de fecho mais alto: $18.99 em 2023-11-01

Preço de fecho mais baixo: $19.35 em 2012-10-01
Histórico de preços das ações da Intercept Pharmaceuticals, Inc. de 2012 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2023 39.35%
2022 -16.08%
2021 -46.76%
2020 -74.21%
2019 16.21%
2018 65.23%
2017 -41.82%
2016 -32.31%
2015 8.19%
2014 138.13%
2013 92.89%
2012 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $542.09 38.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 44.13%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.36 -12.82%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.18 473.58%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $759.27 7.20%
CH